Implementation and outcomes of recommended folic acid supplementation in Mexican-American women with prior neural tube defect-affected pregnancies

Prev Med. 2005 Jun;40(6):867-71. doi: 10.1016/j.ypmed.2004.10.006.

Abstract

Background: Upon discovering an NTD incidence rate of 27/10,000 in a Texas border county, the Texas Department of Health initiated folic acid intervention for prevention of recurrent NTDs in this predominantly Mexican-American population. This paper describes compliance of this population with USPHS folic acid recommendations and the impact of supplementation on pregnancy outcomes.

Methods: Based upon information from active surveillance, field teams personally contacted women having NTD-affected pregnancies to enroll them in FA intervention. Enrollees were provided FA at home visits at 3-month intervals throughout the project.

Results: Of 405 women identified with NTD-affected pregnancies, 299 (73.8%) enrolled in the intervention. One hundred ninety-three pregnancies occurred among 138 women. FA supplementation of 0.4 mg/day or more occurred during the last month preconception in 161 (83.4%) of the 193 pregnancies. No NTDs were detected in the 130 livebirths to women who received supplementation nor were NTDs detected in the 23 supplemented women who experienced pregnancy loss.

Conclusions: Supplementation was successful in preventing recurrent NTDs in Mexican-American women.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Case-Control Studies
  • Cohort Studies
  • Dietary Supplements*
  • Female
  • Folic Acid / administration & dosage*
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Incidence
  • Maternal Age
  • Mexican Americans / statistics & numerical data*
  • Neural Tube Defects / ethnology*
  • Neural Tube Defects / prevention & control*
  • Parity
  • Pregnancy
  • Pregnancy, High-Risk*
  • Prenatal Care / methods
  • Probability
  • Reference Values
  • Risk Assessment
  • Treatment Outcome

Substances

  • Folic Acid